Adicet Bio Inc (ACET)
2.35
+0.03
(+1.29%)
USD |
NASDAQ |
Mar 28, 16:00
2.35
0.00 (0.00%)
After-Hours: 20:00
Adicet Bio Cash from Operations (TTM): -93.72M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -93.72M |
September 30, 2023 | -89.07M |
June 30, 2023 | -83.16M |
March 31, 2023 | -72.96M |
December 31, 2022 | -44.76M |
September 30, 2022 | -39.37M |
June 30, 2022 | -33.73M |
Date | Value |
---|---|
March 31, 2022 | -31.80M |
December 31, 2021 | -51.05M |
September 30, 2021 | -50.95M |
June 30, 2021 | -49.12M |
March 31, 2021 | -48.35M |
December 31, 2020 | -41.55M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-93.72M
Minimum
Dec 2023
-31.80M
Maximum
Mar 2022
-56.12M
Average
-49.12M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
LifeMD Inc | 8.820M |
ABVC BioPharma Inc | -4.236M |
NexImmune Inc | -36.72M |
Omega Therapeutics Inc | -98.66M |
Sagimet Biosciences Inc | -24.14M |